Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbα antibodies
Authors:
- 1 August 2006
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 108 (3) , 943-946
Abstract
Intravenous immunoglobulin G (IVIG) is used to treat idiopathic thrombocytopenic purpura (ITP). Although many patients benefit from IVIG, some are refractory to this therapy. ITP is characterized by platelet clearance mediated primarily by antiplatelet antibodies against GPIIbIIIa and/or the GPIbα complex. These 2 groups of antibodies may induce ITP through different mechanisms. We tested the hypothesis that IVIG may not be equally effective in preventing ITP caused by anti-GPIIbIIIa versus anti-GPIbα antibodies in mice. Thrombocytopenia was induced in BALB/c mice using monoclonal antibodies against either mouse GPIIbIIIa (JON1, JON2, and JON3) or GPIbα (p0p3, p0p4, p0p5, p0p9, and p0p11). Pretreatment with IVIG significantly ameliorated ITP in all anti-GPIIbIIIa–injected animals. Conversely, IVIG failed to prevent ITP in all anti-GPIbα–treated mice, except for p0p4. These results were repeated in C57BL/6 mice, and with different IVIG preparations. These data in mice suggest that patients with ITP mediated by anti-GPIbα antibodies may be less responsive to IVIG treatment.Keywords
This publication has 23 references indexed in Scilit:
- Antiplatelet Antibodies in Chronic Adult Immune Thrombocytopenic Purpura: Assays and EpitopesJournal of Pediatric Hematology/Oncology, 2003
- Mechanism of action of IVIG and anti-D in ITPTransfusion and Apheresis Science, 2003
- Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adultsBritish Journal of Haematology, 2002
- Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in miceBlood, 2000
- Idiopathic immune thrombocytopenic purpura: An updateSeminars in Hematology, 2000
- Platelet Autoantibodies in Immune Thrombocytopenic PurpuraTransfusion Science, 1998
- New therapeutic avenues in autoimmunityResearch in Immunology, 1996
- Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpuraBlood, 1994
- Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulinBlood, 1993
- PLATELET AUTOANTIGENS IN CHRONIC ITPBritish Journal of Haematology, 1984